Brief: Entero Therapeutics Says Immunogenx Received Notice Of Default, Demand For Payment Relating To Credit Agreement

GridAI Technologies

27/11/2024 23:24

Nov 27 (Reuters) - Entero Therapeutics Inc  ENTO.O :
    * ENTERO THERAPEUTICS: ON NOV 21, IMMUNOGENX RECEIVED NOTICE
OF
DEFAULT, DEMAND FOR PAYMENT RELATING TO CREDIT AGREEMENT, DATED
AS OF OCT 3, 2022
    * ENTERO THERAPEUTICS : NOTICE INFORMED IMMUNOGENX THAT ONE
OR
MORE EVENTS OF DEFAULT UNDER CREDIT AGREEMENT WERE EXISTING AND
CONTINUING
    * ENTERO THERAPEUTICS INC: ACCELERATION OR REDUCTION OF CASH
OUTFLOWS AND DEBT OBLIGATIONS CAN SIGNIFICANTLY IMPACT OUR
ABILITY TO MAINTAIN OPERATIONS
    * ENTERO THERAPEUTICS INC: HAVE REDUCED HEADCOUNT AND PAUSED
DEVELOPMENT ACTIVITIES
    * ENTERO THERAPEUTICS INC: EXPLORING STRATEGIC ALTERNATIVES
FOR
PURPOSE OF MAXIMIZING VALUE OF ALL OF OUR STAKEHOLDERS
    * ENTERO THERAPEUTICS INC: EXPECT TO CONTINUE TO, EXPLORE
VARIOUS
POTENTIAL STRATEGIES AVAILABLE TO CO

Source text:  ID:n0001104659-24-123742 
Further company coverage:  ENTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))